What is the treatment for pseudo gout (calcium pyrophosphate deposition disease)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Pseudogout (Calcium Pyrophosphate Deposition Disease)

For acute attacks of pseudogout, first-line treatment includes NSAIDs, colchicine, or corticosteroids (oral or intra-articular), with joint aspiration and ice packs providing additional relief. 1

Acute Attack Management

  • Joint aspiration combined with intra-articular long-acting glucocorticosteroid injection is highly effective for monoarticular or oligoarticular attacks, providing rapid symptom relief 1
  • Application of ice or cool packs and temporary rest of the affected joint(s) help reduce inflammation and pain 1
  • Oral NSAIDs are effective first-line agents, with dosing similar to that used in acute gout attacks 1
  • Colchicine at lower doses (0.5 mg up to three to four times daily with or without loading dose of 1 mg) is recommended to minimize side effects while maintaining efficacy 1
  • For patients with contraindications to NSAIDs and colchicine, oral corticosteroids (e.g., prednisone) can be used effectively 1

Prophylactic Treatment

  • For patients with frequent recurrent attacks, prophylactic low-dose colchicine (0.5-1 mg daily) may be considered 1
  • NSAIDs at lower doses can also be used for prophylaxis in patients who tolerate them well 1
  • Unlike gout, there is no specific urate-lowering therapy for pseudogout as the disease involves calcium pyrophosphate crystals rather than uric acid 1

Management of Chronic CPPD

  • Treatment should be individualized based on clinical presentation, severity, and comorbidities 1
  • For patients with CPPD associated with osteoarthritis, standard OA management approaches should be employed, including:
    • Physical therapy and appropriate exercise programs 1
    • Weight loss if overweight or obese 1
    • Analgesics for pain control 1

Special Considerations

  • In patients with pseudogout secondary to metabolic disorders (hyperparathyroidism, hemochromatosis, hypomagnesemia), treating the underlying condition is essential 1
  • For patients with chronic renal failure, dosing adjustments for medications like colchicine and NSAIDs are crucial to avoid toxicity 2
  • Spinal involvement with pseudogout is rare but can present with neck pain or even myeloradiculopathy, requiring surgical intervention in cases of spinal cord compression 3, 4

Common Pitfalls to Avoid

  • Misdiagnosis is common as pseudogout can mimic gout, rheumatoid arthritis, or osteoarthritis; definitive diagnosis requires identification of calcium pyrophosphate crystals in synovial fluid 5
  • Unlike gout, pseudogout does not always show chondrocalcinosis on radiographs, so absence of calcification does not rule out the diagnosis 5
  • Overuse of colchicine with traditional high-dose regimens can lead to severe gastrointestinal side effects; lower doses are now recommended 1
  • Long-term NSAID use carries significant risks, particularly in elderly patients who commonly develop pseudogout, including gastrointestinal, renal, and cardiovascular complications 1

Treatment Algorithm

  1. For acute attacks:

    • First step: Joint aspiration (if feasible) + intra-articular corticosteroid injection for monoarticular presentation
    • For polyarticular attacks or when joint injection is not possible: Oral NSAIDs, colchicine, or systemic corticosteroids
    • Adjunctive measures: Ice application and rest of affected joint(s)
  2. For frequent recurrent attacks:

    • Consider prophylactic low-dose colchicine or NSAIDs
    • Identify and treat any underlying metabolic disorder
  3. For chronic CPPD with osteoarthritis:

    • Focus on symptom management with physical therapy, appropriate exercise
    • Use analgesics as needed for pain control
    • Consider assistive devices if functional limitations are present

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute pseudogout in chronic renal failure.

Archives of internal medicine, 1979

Research

Cervical myeloradiculopathy as an initial presentation of pseudogout.

Neurosciences (Riyadh, Saudi Arabia), 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.